HM Payson & Co’s Nu Skin NUS Stock Holding History

HM Payson & Co’s Portfolio NUS Stock Details NUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-470	Closed	-$10K	–	909
2020 Q1	$10K	Buy	+470	New	+$14.1K	﹤0.01%	734

Other funds holding NUS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

HM Payson & Co's NUS Position: Q2 2020 in Review

HM Payson & Co sold out of Nu Skin (NUS) in Q2 2020, closing a stake of 470 shares — an estimated $10K sold.

HM Payson & Co first reported a position in NUS in Q1 2020 and held it in 1 quarter. The position peaked at $10K in Q1 2020. 226 funds tracked by Wall St. Rank hold NUS as of Q2 2020.

HM Payson & Co reported no remaining Nu Skin position as of Q2 2020 after selling out during the quarter.
HM Payson & Co sold 470 Nu Skin shares in Q2 2020, an estimated $10K.
HM Payson & Co first reported a position in Nu Skin in Q1 2020 and held it in 1 quarter.
HM Payson & Co's Nu Skin position peaked at $10K in Q1 2020.
226 funds tracked by Wall St. Rank held Nu Skin as of Q2 2020.

Based on HM Payson & Co's 13F filing for Q2 2020, filed 13 Aug 2020.